Supermax Drugs & Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Narela, Delhi, India, established in 1994.
1994 Narela, Delhi, India Active
Last Updated:
Access Report
About Supermax Drugs & Pharmaceuticals Private Limited

Supermax Drugs & Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 1994 in Narela, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74899DL1994PTC058598. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.00 M.

It upholds a compliant status. Employing 153 professional, Its leadership includes Thakar Dass Bhatia (Director), Aloke Ghosh (Director), Chetan Bhatia (Director). Past directors included Khand Chand Bhatia, Prem Kumar Bhatia, Suresh Kumar Bhatia. It holds ₹27.34 Cr open charges and ₹8.40 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No. 1231, 2Nd Floor Blk-H Dsidc Narela, City Delhi, Landmark Na, Narela, Delhi, 110040.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1994PTC058598

  • Registration Number

    058598

  • Incorporation Date

    25 April 1994

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 3.00 M
  • Company Age 31 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 27.34 Cr
  • Satisfied Charges ₹ 8.40 M
  • Revenue Growth **** 40.02%
  • Profit Growth **** 87.63%
  • Ebitda **** 141.12%
  • Net Worth 57.77%
  • Total Assets **** 15.48%
Company report

Supermax Drugs & Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Supermax Drugs & Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Supermax Drugs & Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Thakar Dass Bhatia Director 25 Apr 1994 Current
Aloke Ghosh Director 11 Dec 2019 Current
Chetan Bhatia Director 10 Apr 2019 Current
Saurabh Bhatia Director 10 Apr 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jun 2013 Past
Pramod Abcsdd Director 06 Jun 2013 Past
Pramod Abcsdd Director 10 Apr 2019 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supermax Drugs & Pharmaceuticals.

Supermax Drugs & Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 40.02% increase. The company also saw a substantial improvement in profitability, with a 87.63% increase in profit. The company's net worth Soared by an impressive increase of 57.77%.

Supermax Drugs & Pharmaceuticals revenue growth over time
Supermax Drugs & Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.02%
*******
*******
*******
*******
Revenue from Operations
*******
 39.88%
*******
*******
*******
*******
Total Assets
*******
 15.48%
*******
*******
*******
*******
Profit or Loss
*******
 87.63%
*******
*******
*******
*******
Net Worth
*******
 57.77%
*******
*******
*******
*******
EBITDA
*******
 141.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supermax Drugs & Pharmaceuticals?

In 2024, Supermax Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹273,384,600.00

Satisfied Charges

₹8,400,000.00

Charges Breakdown by Lending Institutions
  • Others : 26.82 Cr
  • Tata Capital Financial Services Limited : 0.42 Cr
  • Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
31 May 2025 Hdfc Bank Limited ₹0.97 M Open
08 Nov 2023 Tata Capital Financial Services Limited ₹1.31 M Open
28 Dec 2022 Tata Capital Financial Services Limited ₹2.90 M Open
13 Jul 2020 Others ₹8.20 M Open
21 Nov 2019 Others ₹26.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Supermax Drugs & Pharmaceuticals?

Supermax Drugs & Pharmaceuticals has a workforce of 153 employees as of May 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supermax Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supermax Drugs & Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supermax Drugs & Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 26.00 Cr registered on 21 Nov 2019 with Charge ID 100306348 was modified on 21 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Supermax Drugs & Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 101124074 was registered on 31 May 2025. was documented.

  • Balance Sheet

    Progress on Supermax Drugs & Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Charges

    A charge with Tata Capital Financial Services Limited amounted to Rs. 0.13 Cr with Charge ID 100817370 was registered on 08 Nov 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Tata Capital Financial Services Limited amounted to Rs. 0.29 Cr with Charge ID 100672332 was registered on 28 Dec 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Supermax Drugs & Pharmaceuticals Private Limited?

The CIN of Supermax Drugs & Pharmaceuticals Private Limited is U74899DL1994PTC058598.

Where is Supermax Drugs & Pharmaceuticals Private Limited headquartered?

Supermax Drugs & Pharmaceuticals Private Limited is headquartered at Plot No. 1231, 2Nd Floor Blk-H Dsidc Narela, City Delhi, Landmark Na, Narela, Delhi, 110040.

When was Supermax Drugs & Pharmaceuticals Private Limited incorporated?

Supermax Drugs & Pharmaceuticals Private Limited was incorporated on 25 April 1994.

Who are the current directors of Supermax Drugs & Pharmaceuticals Private Limited?

The current directors of Supermax Drugs & Pharmaceuticals Private Limited are

What is the primary industry of Supermax Drugs & Pharmaceuticals Private Limited?

The primary industry of Supermax Drugs & Pharmaceuticals Private Limited is Trade.

Is Supermax Drugs & Pharmaceuticals Private Limited a listed company?

Supermax Drugs & Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Supermax Drugs & Pharmaceuticals Private Limited?

The authorized capital of Supermax Drugs & Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹3.00 M.

What is the compliance status of Supermax Drugs & Pharmaceuticals Private Limited?

The compliance status of Supermax Drugs & Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available